MARATTO

article · International Journal of Vaccines & Vaccination

Perception of the Congolese population on Covid-19 vaccination: cross-sectional survey of online

20216 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

COVID-19 vaccines will become available in Democratic Republic of Congo soon. Understanding communities’ responses to the forthcoming COVID-19 vaccines is important. We was conducted an analytical cross-sectional study online in 26 provinces of the Democratic Republic of Congo during the period from January to March 2021. A total of 11971 responses were included; mean age of respondents was 35.1±10.4 years; 79.4% were males; 90.5% had university school education and 55.4% has a high socioeconomic level. A frequency of poor perception of covid-19 vaccination is 75.6%. In a multivariable regression model, age between 46-55 years, 36-45 years and 26-35 years (aOR=1.54, CI: 1.27-1.87, aOR=1.70 CI: 1.35-2.13 and aOR =3.40, CI: 2.78–4.17, respectively), None profession and liberal profession (aOR=1.75, CI: 1.49-3.34 and aOR=2.52, CI: 1.89-3.34, respectively), moderate and low socioeconomic level (aOR=3.06, CI: 2.64-3.56 and aOR=5.89, CI: 4.11- 8.38, respectively), Low and very low risk of infection with COVID-19 (aOR=1.67, CI: 1.07-1.97 and OR=2.66, CI: 1.36-3.04, respectively; Moderate, low and very low risk of getting sick if you are infected (aOR=1.49, CI: 2.08-2.98, aOR=2.97 CI: 2.45-3.59 and aOR=3.89, CI: 3.11-4.82, respectively) were associated with a poor perception COVID-19 vaccination. In conclusion, the frequency of misperception in the Congolese population is high. It is associated with the poor perception of the disease and the socio-demographic characteristics of individuals.

Research topics

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 epidemiological studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.15406/ijvv.2021.06.00110

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.